HEAL
Global X HealthTech ETF
The Global X HealthTech ETF invests in companies transforming healthcare through cutting-edge technology.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 23.7 M
ASSETS UNDER MGMT
50 bp
EXPENSES
Fund Basics
| Inception date | Jul 28, 2020 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| MASIMO CORPORATION | 6.4 % |
| DEXCOM INC | 5.8 % |
| KONINKLIIJKE ELECTRONICS NV | 5.0 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 4.9 % |
| RESMED INC | 4.5 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LT | 4.4 % |
| TRANSMEDICS GROUP, INC. | 4.3 % |
| INTUITIVE SURGICAL INC | 4.2 % |
| IQVIA HOLDINGS INC | 4.0 % |
| IRHYTHM TECHNOLOGIES, INC. | 3.5 % |
Constituent Breakdown
| Number of holdings | 40 |
| Herfindahl-Hirschman Index | 356 |
| Wgt avg mkt cap (mns) | $20,909 |
| Large cap (>$10bn) | 43.5% |
| Mid cap ($2-10bn) | 33.9% |
| Small cap (<$2bn) | 13.3% |
| Developed mkts. | 100.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 73.1 % |
 |
NETHERLANDS | 5.0 % |
 |
HONG KONG | 4.4 % |
 |
DENMARK | 2.9 % |
 |
AUSTRALIA | 2.6 % |
 |
BRITAIN | 1.6 % |
 |
CANADA | 0.7 % |
Historical Performance
Standardized Performance (as of 02/28/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -8.9% | -15.4% | -3.4% | -8.7% | -15.1% | -- | -- | -9.6% |
| Dividend Yield | 0.0% | 0.3% | 0.2% | 0.1% | 0.1% | -- | -- | 0.1% |
| Total Returns | -8.9% | -15.2% | -3.3% | -8.6% | -15.1% | -- | -- | -9.5% | Ann. Volatility | 25.4% | 25.2% | 24.7% | 24.6% | 26.6% | -- | -- | 26.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.95 | 52% |
| MSCI EAFE | 1.00 | 41% |
| MSCI Emg Mkts | 0.83 | 34% |
Liquidity Measures
| Avg. volume (000) | 13 |
| ADV traded (mns) | $0 |
| Turnover | 1.3% |
| Avg. Bid/Ask (% of price) | 1.64% |
Technical Indicators
| 30d moving avg. (EMA) | $25.56 |
| Relative strength (RSI) | 32 |
| MACD/Signal | -0.76/-0.69 |
| Bollinger Bands (Upper/Lower) | $26.88/$23.50 |
| Short interest (% of AUM) | 1.3% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. HEAL |
Expenses vs. HEAL |
ALTAR Score™ vs. HEAL |
|---|---|---|---|---|
| FDHT | Fidelity Digital Health ETF | 46.8% | -11 bp | +2.8% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 41.2% | +15 bp | +1.9% |
| IHI | iShares U.S. Medical Devices ETF | 21.6% | -10 bp | +5.6% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 20.9% | -15 bp | +4.7% |
| FMED | Fidelity Disruptive Medicine ETF | 20.0% | 0 bp | -0.6% |
| MDEV | First Trust Indxx Medical Devices ETF | 16.2% | +20 bp | +5.9% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 14.9% | +18 bp | +3.1% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 10.8% | +25 bp | +2.1% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 10.3% | +10 bp | -0.6% |
Risk and Returns: HEAL vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/3/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-0.6%
ALTAR SCORE™
3rd
PERCENTILE
AVOID
ETFRC RATING
There are 579 funds in the Global Equity category with an average
ALTAR Score™ of 4.6% and a standard deviation
of 2.7%. HEAL's ALTAR Score™ is approximately -1.9 standard
deviations above the category average. This places HEAL in the 3rd percentile
among funds in the category.
Sell-Side Consensus
$35.38
PRICE TARGET
+49.1%
UPSIDE
Bid/Ask Spreads
164 bp
AVG SPREAD
55 —
882 bp
RANGE